NCT01975129View on ClinicalTrials.gov

A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Vaginal Atrophy
Interventions
DRUG

Vagitocin

Trial Locations (1)

SE-141 86

Women's health clinic, Stockholm

Sponsors
All Listed Sponsors
lead

PepTonic Medical AB

INDUSTRY

NCT01975129 - A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin | Biotech Hunter | Biotech Hunter